Cargando…
In Vitro Mutational Analysis of the β(2) Adrenergic Receptor, an In Vivo Surrogate Odorant Receptor
Many G-protein coupled receptors (GPCRs), such as odorant receptors (ORs), cannot be characterized in heterologous cells because of their difficulty in trafficking to the plasma membrane. In contrast, a surrogate OR, the GPCR mouse β2-adrenergic-receptor (mβ2AR), robustly traffics to the plasma memb...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626089/ https://www.ncbi.nlm.nih.gov/pubmed/26513247 http://dx.doi.org/10.1371/journal.pone.0141696 |
_version_ | 1782398073878609920 |
---|---|
author | Jamet, Sophie Bubnell, Jaclyn Pfister, Patrick Tomoiaga, Delia Rogers, Matthew E. Feinstein, Paul |
author_facet | Jamet, Sophie Bubnell, Jaclyn Pfister, Patrick Tomoiaga, Delia Rogers, Matthew E. Feinstein, Paul |
author_sort | Jamet, Sophie |
collection | PubMed |
description | Many G-protein coupled receptors (GPCRs), such as odorant receptors (ORs), cannot be characterized in heterologous cells because of their difficulty in trafficking to the plasma membrane. In contrast, a surrogate OR, the GPCR mouse β2-adrenergic-receptor (mβ2AR), robustly traffics to the plasma membrane. We set out to characterize mβ2AR mutants in vitro for their eventual use in olfactory axon guidance studies. We performed an extensive mutational analysis of mβ2AR using a Green Fluorescent Protein-tagged mβ2AR (mβ2AR::GFP) to easily assess the extent of its plasma membrane localization. In order to characterize mutants for their ability to successfully transduce ligand-initiated signal cascades, we determined the half maximal effective concentrations (EC50) and maximal response to isoprenaline, a known mβ2AR agonist. Our analysis reveals that removal of amino terminal (Nt) N-glycosylation sites and the carboxy terminal (Ct) palmitoylation site of mβ2AR do not affect its plasma membrane localization. By contrast, when both the Nt and Ct of mβ2AR are replaced with those of M71 OR, plasma membrane trafficking is impaired. We further analyze three mβ2AR mutants (RDY, E268A, and C327R) used in olfactory axon guidance studies and are able to decorrelate their plasma membrane trafficking with their capacity to respond to isoprenaline. A deletion of the Ct prevents proper trafficking and abolishes activity, but plasma membrane trafficking can be selectively rescued by a Tyrosine to Alanine mutation in the highly conserved GPCR motif NPxxY. This new loss-of-function mutant argues for a model in which residues located at the end of transmembrane domain 7 can act as a retention signal when unmasked. Additionally, to our surprise, amongst our set of mutations only Ct mutations appear to lower mβ2AR EC50s revealing their critical role in G-protein coupling. We propose that an interaction between the Nt and Ct is necessary for proper folding and/or transport of GPCRs. |
format | Online Article Text |
id | pubmed-4626089 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-46260892015-11-06 In Vitro Mutational Analysis of the β(2) Adrenergic Receptor, an In Vivo Surrogate Odorant Receptor Jamet, Sophie Bubnell, Jaclyn Pfister, Patrick Tomoiaga, Delia Rogers, Matthew E. Feinstein, Paul PLoS One Research Article Many G-protein coupled receptors (GPCRs), such as odorant receptors (ORs), cannot be characterized in heterologous cells because of their difficulty in trafficking to the plasma membrane. In contrast, a surrogate OR, the GPCR mouse β2-adrenergic-receptor (mβ2AR), robustly traffics to the plasma membrane. We set out to characterize mβ2AR mutants in vitro for their eventual use in olfactory axon guidance studies. We performed an extensive mutational analysis of mβ2AR using a Green Fluorescent Protein-tagged mβ2AR (mβ2AR::GFP) to easily assess the extent of its plasma membrane localization. In order to characterize mutants for their ability to successfully transduce ligand-initiated signal cascades, we determined the half maximal effective concentrations (EC50) and maximal response to isoprenaline, a known mβ2AR agonist. Our analysis reveals that removal of amino terminal (Nt) N-glycosylation sites and the carboxy terminal (Ct) palmitoylation site of mβ2AR do not affect its plasma membrane localization. By contrast, when both the Nt and Ct of mβ2AR are replaced with those of M71 OR, plasma membrane trafficking is impaired. We further analyze three mβ2AR mutants (RDY, E268A, and C327R) used in olfactory axon guidance studies and are able to decorrelate their plasma membrane trafficking with their capacity to respond to isoprenaline. A deletion of the Ct prevents proper trafficking and abolishes activity, but plasma membrane trafficking can be selectively rescued by a Tyrosine to Alanine mutation in the highly conserved GPCR motif NPxxY. This new loss-of-function mutant argues for a model in which residues located at the end of transmembrane domain 7 can act as a retention signal when unmasked. Additionally, to our surprise, amongst our set of mutations only Ct mutations appear to lower mβ2AR EC50s revealing their critical role in G-protein coupling. We propose that an interaction between the Nt and Ct is necessary for proper folding and/or transport of GPCRs. Public Library of Science 2015-10-29 /pmc/articles/PMC4626089/ /pubmed/26513247 http://dx.doi.org/10.1371/journal.pone.0141696 Text en © 2015 Jamet et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Jamet, Sophie Bubnell, Jaclyn Pfister, Patrick Tomoiaga, Delia Rogers, Matthew E. Feinstein, Paul In Vitro Mutational Analysis of the β(2) Adrenergic Receptor, an In Vivo Surrogate Odorant Receptor |
title |
In Vitro Mutational Analysis of the β(2) Adrenergic Receptor, an In Vivo Surrogate Odorant Receptor |
title_full |
In Vitro Mutational Analysis of the β(2) Adrenergic Receptor, an In Vivo Surrogate Odorant Receptor |
title_fullStr |
In Vitro Mutational Analysis of the β(2) Adrenergic Receptor, an In Vivo Surrogate Odorant Receptor |
title_full_unstemmed |
In Vitro Mutational Analysis of the β(2) Adrenergic Receptor, an In Vivo Surrogate Odorant Receptor |
title_short |
In Vitro Mutational Analysis of the β(2) Adrenergic Receptor, an In Vivo Surrogate Odorant Receptor |
title_sort | in vitro mutational analysis of the β(2) adrenergic receptor, an in vivo surrogate odorant receptor |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626089/ https://www.ncbi.nlm.nih.gov/pubmed/26513247 http://dx.doi.org/10.1371/journal.pone.0141696 |
work_keys_str_mv | AT jametsophie invitromutationalanalysisoftheb2adrenergicreceptoraninvivosurrogateodorantreceptor AT bubnelljaclyn invitromutationalanalysisoftheb2adrenergicreceptoraninvivosurrogateodorantreceptor AT pfisterpatrick invitromutationalanalysisoftheb2adrenergicreceptoraninvivosurrogateodorantreceptor AT tomoiagadelia invitromutationalanalysisoftheb2adrenergicreceptoraninvivosurrogateodorantreceptor AT rogersmatthewe invitromutationalanalysisoftheb2adrenergicreceptoraninvivosurrogateodorantreceptor AT feinsteinpaul invitromutationalanalysisoftheb2adrenergicreceptoraninvivosurrogateodorantreceptor |